John Bennett, Head of European Equities at Henderson, discusses the value opportunities created by the Greek crisis, whether the recovery in Europe is sustainable and who may be the potential winners. He also reviews his long-standing theme in pharmaceuticals and discusses whether he believes that quality growth stock are now over-priced.